Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.
Schildkraut JM; Calingaert B; Marchbanks PA; Moorman PG; Rodriguez GC; Journal Of The National Cancer Institute, 2002, vol. 94, issue 1, p 32, ISSN 00278874. ISBN 00278874.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef